None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Those aged 19 to 64 2. Those with a Visual Analogue Scale (VAS) score of 30 or higher for muscle pain (lumbar region) 3. Those who have been fully explained about the purpose, content, and clinical research device of the trial prior to participating in the trial and voluntarily decided to participate in the clinical trial and gave written consent 4. Those who can be followed up during the trial period
Exclusion criteria
Exclusion criteria: 1. Patients who have had lumbar surgery within 3 months 2. Those who have undergone lumbar-related procedures within the past month 3. Those using implantable electronic medical devices such as implantable pacemakers 4. Those who cannot rub due to skin disease, inflammation, wounds, etc. 5. Those currently taking steroids, immunosuppressants, psychiatric medications, or other medications that may affect the results of the study 6. Those with impaired mobility and a high risk of falling 7. Pregnant women, those who have just given birth, and breastfeeding women 8. Others deemed unsuitable for the study by the principal investigator 9. Those who have participated in a clinical trial with another intervention method within 30 days of participating in the study 10. Those diagnosed with osteoporosis and taking osteoporosis medication
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Muscle Pain Pain Scale (Visual Analogue Scale) | — |
Secondary
| Measure | Time frame |
|---|---|
| Stress resistance measured by Heart Rate Variability;Stress index measured by Heart Rate Variability;Fatigue measured by Heart Rate Variability;TP (total power) measured by Heart Rate Variability;Mean HRT (heart rate) measured by Heart Rate Variability;SDNN (Standard Deviation of all Normal R-R Intervals) measured by Heart Rate Variability;The Square Root of The Mean of The Sum of The Squares of Differences Between Adjacent Normal R-R Intervals (RMSSD) as measured by Heart Rate Variability;Adverse effect | — |
Countries
Korea, Republic of
Contacts
Cheonan Korean Medicine Hospital of Daejeon University